Home › Research › Clinical safety
Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension
Giulia Rivasi, Marco Capacci, Lorenzo Maria Del Re, Ilaria Ambrosino, Ludovica Ceolin, Alessandra Liccardo, Maria Francesca Bisignano, Giuseppe D’Ambrosio et al.. Drugs & Aging, 2025-03-11
Topic: Brain proteins, microglia and lab models
Plain-language summary
In older adults, trazodone is frequently prescribed for anxiety and insomnia owing to its perceived greater tolerability in comparison with benzodiazepines. However, it may have hypotensive effects. The aim of this study is to investigate the effects of trazodone on orthostatic blood pressure (BP) response and risk of syncope and falls in hypertensive older adults. A longitudinal observational study involving patients ≥ 75 years was conducted in two geriatric outpatient clinics in Florence, Italy. At baseline, participants underwent a 3-min active stand test, office BP measurement and home and ambulatory BP monitoring. At follow-up, syncope and falls were recorded. Among 123 participants (mean age 81 years, 59% female), 12 (10%) reported regular trazodone use. Trazodone users showed lower office diastolic BP (71.8 versus 80.1 mmHg, p = 0.042), a greater systolic and diastolic BP reduction immediately after standing (Δsystolic T0 23.8 versus 14.3 mmHg, p = 0.037; Δdiastolic T0 8.9 versus 1.6 mmHg, p = 0.004) and a greater diastolic BP reduction after 1-min standing (Δdiastolic T1 6.5 versus 0 mmHg, p = 0.029). No differences were reported for home or ambulatory BP. Incidence of syncope and falls was 25%, with a significantly higher rate in patients receiving trazodone (58.3% versus 21.2%, p = 0.001). Trazodone use predicted syncope and falls independently of age, disability and fall history. This association was not confirmed when adjusting for dementia diagnosis. BP values were not associated with the study outcome. In older hypertensive outpatients, trazodone is associated with a greater orthostatic BP drop and may predispose them to an increased risk of syncope and falls.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 123 participants. In this small longitudinal study of older hypertensive outpatients, trazodone use was linked to a greater drop in blood pressure on standing and a higher rate of syncope and falls. Reported effect size: 58.3%; 21.2%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Rivasi, G., Capacci, M., Del Re, L. M., Ambrosino, I., Ceolin, L., Liccardo, A., et al. (2025). Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension. Drugs & Aging. https://doi.org/10.1007/s40266-025-01196-3
Vancouver
Rivasi G, Capacci M, Del Re LM, Ambrosino I, Ceolin L, Liccardo A, et al. Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension. Drugs & Aging. 2025. doi:10.1007/s40266-025-01196-3. PMID: 40067602.
BibTeX
@article{rivasi2025-40067602,
author = {Rivasi, Giulia and Capacci, Marco and Del Re, Lorenzo Maria and Ambrosino, Ilaria and Ceolin, Ludovica and Liccardo, Alessandra and Bisignano, Maria Francesca and D’Ambrosio, Giuseppe and others},
title = {{Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension}},
journal = {Drugs \& Aging},
year = {2025},
doi = {10.1007/s40266-025-01196-3},
pmid = {40067602},
url = {https://doi.org/10.1007/s40266-025-01196-3}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Trazodone users showed lower office diastolic BP (71.8 versus 80.1 mmHg, p = 0.042), a greater systolic and diastolic BP reduction immediately after standing (Δsystolic T0 23.8 versus 14.3 mmHg, p = 0.037; Δdiastolic T0 8.9 versus 1.6 mmHg, p = 0.004) and a greater diastolic BP reduction after 1-min standing (Δdiastolic T1 6.5 versus 0 mmHg, p = 0.029).
- Incidence of syncope and falls was 25%, with a significantly higher rate in patients receiving trazodone (58.3% versus 21.2%, p = 0.001).
- BP values were not associated with the study outcome.
- In older hypertensive outpatients, trazodone is associated with a greater orthostatic BP drop and may predispose them to an increased risk of syncope and falls.
Why it matters
In this small longitudinal study of older hypertensive outpatients, trazodone use was linked to a greater drop in blood pressure on standing and a higher rate of syncope and falls. It is an observational study of a medication's risks, not a treatment or cure for Alzheimer's disease.
Study details
- Study designlongitudinal study
- Participants123
- Effect size58.3%; 21.2%
- Evidence strengthModerate
How this study scored 54/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Drugs & Aging) |
| Journal's citation record | 1 / 4 | Drugs & Aging: journal h-index 135 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 123 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 4 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 3.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Andrea Ungar: h-index 56 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Florence: institution h-index 739 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40067602) |
| Free to read | 2 / 2 | Free to read |
| Total | 54 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Clinical safety from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.